PharmaCielo Ltd. (PCLO.V)
| Previous Close | 0.1550 |
| Open | 0.1550 |
| Bid | 0.1600 x 0 |
| Ask | 0.1650 x 0 |
| Day's Range | 0.1550 - 0.1650 |
| 52 Week Range | 0.1050 - 0.2900 |
| Volume | |
| Avg. Volume | 169,098 |
| Market Cap | 28.114M |
| Beta (5Y Monthly) | 2.48 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0800 |
| Earnings Date | Apr 29, 2024 - May 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NewsfilePharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors
The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product.Experienced investor, businessman and lawyer Louis Desmarais, the current Chairman and CEO of Siam Ventures, will join the Company's board of directors on closing./NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/All amounts expressed in Canadian dollars unless otherwis
NewsfilePharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil
The contract to supply the State of São Paulo is the largest public sector contract awarded to date in Brazil - the State of São Paulo is the largest state in the country. Ease Labs to supply up to 1.871 tons of pharma-grade CBD to the government over a 12-month period. Ease Labs' product is based on PharmaCielo's proprietary API.Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - March 26, 2024) - PharmaCielo Ltd. (TSXV: PCLO) ...
NewsfileColombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - March 1, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today commented on the recent decision by the Colombian Ministries of Health, Justice, and Agriculture (the "Ministries") to extend the timeframe within which THC products m
